Literature DB >> 6519149

Pharmacokinetics of mepindolol in patients with chronic renal failure.

W Krause, D Kampf, H C Fischer.   

Abstract

Five patients with a creatinine clearance of 14 to 37 ml/min/1.73 m2 were each given an oral dose of 10 mg of the beta-blocker mepindolol sulphate (Corindolan). In addition, two dialysis patients received the same dose either during hemodialysis or on a dialysis-free day. Plasma levels of mepindolol were measured by a sensitive, specific HPLC method. Mepindolol was rapidly absorbed in all the patients. The maximum plasma level of 35 +/- 8 ng/ml was reached after 1.4 +/- 0.5 h. The half-life of disposition was 4.0 +/- 1.5 h. The area under the plasma concentration-time curve was 237 +/- 84 ng X h/ml. The data obtained were no different from those found in normal healthy volunteers.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6519149     DOI: 10.1007/bf00549590

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  21 in total

Review 1.  [Pharmacokinetic perturbations in kidney failure. Anomalies of metabolites and tissue diffusion (author's transl)].

Authors:  J Fabre; L Balant; M Rudhardt; P Blanchard
Journal:  Nouv Presse Med       Date:  1979 Aug 25-Sep 3

2.  Relationship between renal function and elimination kinetics of pindolol in man.

Authors:  S Oie; G Levy
Journal:  Eur J Clin Pharmacol       Date:  1975-12-19       Impact factor: 2.953

3.  Measurement of hydrophobicity, surface activity, local anaesthesia, and myocardial conduction velocity as quantitative parameters of the non-specific membrane affinity of nine -adrenergic blocking agents.

Authors:  D Hellenbrecht; B Lemmer; G Wiethold; H Grobecker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

4.  Isoprenaline antagonism and duration of action in exercise induced tachycardia of three -adrenoceptor blocking drugs: pindolol, LF 17-895 and propranolol.

Authors:  W H Aellig
Journal:  Br J Pharmacol       Date:  1973-03       Impact factor: 8.739

5.  Sotalol kinetics in renal insufficiency.

Authors:  A D Blair; E D Burgess; B M Maxwell; R E Cutler
Journal:  Clin Pharmacol Ther       Date:  1981-04       Impact factor: 6.875

6.  Metabolism of pindolol in patients with renal failure.

Authors:  E E Ohnhaus; H Heidemann; J Meier; G Maurer
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

7.  Determination of plasma mepindolol levels by high-performance liquid chromatography and electrochemical detection.

Authors:  W Krause
Journal:  J Chromatogr       Date:  1980-01-11

8.  Plasma levels of mepindolol in healthy volunteers after oral doses of mepindolol sulphate.

Authors:  W Krause; W Schwartzkopff
Journal:  Arzneimittelforschung       Date:  1983

9.  Pharmacokinetics of sotalol after chronic administration to patients with renal insufficiency.

Authors:  G Berglund; R Descamps; J A Thomis
Journal:  Eur J Clin Pharmacol       Date:  1980-10       Impact factor: 2.953

10.  Plasma and urine concentrations of acebutolol and its acetyl metabolite in patients with renal functional impairment.

Authors:  S Munn; R R Bailey; E Begg; R Ebert; D G Ferry
Journal:  N Z Med J       Date:  1980-04-23
View more
  1 in total

1.  Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup.

Authors:  Josée Bouchard; Greene Shepherd; Robert S Hoffman; Sophie Gosselin; Darren M Roberts; Yi Li; Thomas D Nolin; Valéry Lavergne; Marc Ghannoum
Journal:  Crit Care       Date:  2021-06-10       Impact factor: 9.097

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.